Nipple-Sparing Mastectomy and Immediate Tissue Expander/Implant Breast Reconstruction

2009 ◽  
Vol 124 (6) ◽  
pp. 1772-1780 ◽  
Author(s):  
Constance M. Chen ◽  
Joseph J. Disa ◽  
Virgilio Sacchini ◽  
Andrea L. Pusic ◽  
Babak J. Mehrara ◽  
...  
2020 ◽  
Vol 44 (5) ◽  
pp. 1466-1475 ◽  
Author(s):  
Giuseppe Visconti ◽  
Gianluca Franceschini ◽  
Alessandro Bianchi ◽  
Liliana Barone-Adesi ◽  
Giorgia Garganese ◽  
...  

2020 ◽  
Vol 147 (1) ◽  
pp. 38-45
Author(s):  
Rachel E. Aliotta ◽  
Isis Scomacao ◽  
Eliana F. R. Duraes ◽  
Grzegorz J. Kwiecien ◽  
Paul D. Durand ◽  
...  

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Emi Morioka ◽  
Masakuni Noguchi ◽  
Miki Noguchi ◽  
Masafumi Inokuchi ◽  
Ken-ichi Shimada ◽  
...  

Abstract Background Although the primary treatment for malignant phyllodes tumor (PT) is complete surgical excision with either breast-conserving surgery or total mastectomy, recent technical advances have led to the adoption of nipple-sparing mastectomy (NSM) with immediate breast reconstruction (IBR). Case presentation A 28-year-old woman noticed a mass in her left breast that was rapidly increasing in size. She underwent tumor excision and a histological diagnosis of marked degenerative and necrotic induration suggested benign PT. One year later, however, she was found to have recurrent masses in the left breast on follow-up mammography and sonography. Needle biopsy was performed and the tumor was diagnosed as borderline or malignant PT. She underwent NSM and sentinel lymph-node biopsy with IBR using a tissue expander. Histological examination of the mastectomy specimen showed multiple fibroepithelial tumors with marked stromal overgrowth, focal necrosis, and hemorrhage. Stromal cells showed pleomorphism and a maximal mitotic rate of approximately 25 per 10 high-power fields. The tumor was diagnosed as malignant PT. She did not receive adjuvant chemotherapy or radiation treatment. At 3-year follow-up, the patient remains free of disease and highly satisfied with the cosmetic results. Conclusions NSM with IBR is not a contraindication for malignant PT. It is both curative and can offer an appealing cosmetic option for localized malignant PT.


Gland Surgery ◽  
2018 ◽  
Vol 7 (3) ◽  
pp. 267-272 ◽  
Author(s):  
Gudjon Leifur Gunnarsson ◽  
Lene Nyhøj Heidemann ◽  
Camilla Bille ◽  
Jens Ahm Sørensen ◽  
Jørn Bo Thomsen

Sign in / Sign up

Export Citation Format

Share Document